Task: Answer the multiple choice question.
Question: Which drug exhibits a 1.367\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] COc1ccc(OC)c(CNC(=O)C2CCN(S(C)(=O)=O)CC2)c1
[b] CCc1ccccc1NC(=O)c1cc(S(=O)(=O)N(C)C)ccc1N1CCCC1
[c] CCOc1ccc(S(=O)(=O)Nc2ccc(Cl)cn2)c(C)c1C
Answer: b. CCc1ccccc1NC(=O)c1cc(S(=O)(=O)N(C)C)ccc1N1CCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1ccccc1NC(=O)c1cc(S(=O)(=O)N(C)C)ccc1N1CCCC1
CCc1ccccc1NC(=O)c1cc(S(=O)(=O)N(C)C)ccc1N1CCCC1
5-(dimethylsulfamoyl)-N-(2-ethylphenyl)-2-pyrrolidin-1-ylbenzamide